MERCADOLIBRE INC (MELI) Fundamental Analysis & Valuation

NASDAQ:MELI • US58733R1023

Current stock price

1840.66 USD
+8.73 (+0.48%)
At close:
1850 USD
+9.34 (+0.51%)
Pre-Market:

This MELI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. MELI Profitability Analysis

1.1 Basic Checks

  • MELI had positive earnings in the past year.
  • MELI had a positive operating cash flow in the past year.
  • In the past 5 years MELI has always been profitable.
  • In the past 5 years MELI always reported a positive cash flow from operatings.
MELI Yearly Net Income VS EBIT VS OCF VS FCFMELI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

1.2 Ratios

  • MELI's Return On Assets of 4.68% is fine compared to the rest of the industry. MELI outperforms 66.67% of its industry peers.
  • Looking at the Return On Equity, with a value of 29.59%, MELI belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
  • MELI has a better Return On Invested Capital (16.97%) than 90.00% of its industry peers.
  • MELI had an Average Return On Invested Capital over the past 3 years of 21.88%. This is significantly above the industry average of 8.75%.
  • The last Return On Invested Capital (16.97%) for MELI is well below the 3 year average (21.88%), which needs to be investigated, but indicates that MELI had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.68%
ROE 29.59%
ROIC 16.97%
ROA(3y)5.96%
ROA(5y)4.44%
ROE(3y)35.22%
ROE(5y)27.5%
ROIC(3y)21.88%
ROIC(5y)17.77%
MELI Yearly ROA, ROE, ROICMELI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30 40

1.3 Margins

  • MELI's Profit Margin of 6.91% is fine compared to the rest of the industry. MELI outperforms 73.33% of its industry peers.
  • MELI's Profit Margin has improved in the last couple of years.
  • MELI has a Operating Margin of 11.08%. This is in the better half of the industry: MELI outperforms 80.00% of its industry peers.
  • In the last couple of years the Operating Margin of MELI has grown nicely.
  • With a Gross Margin value of 44.50%, MELI perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MELI has remained more or less at the same level.
Industry RankSector Rank
OM 11.08%
PM (TTM) 6.91%
GM 44.5%
OM growth 3Y3.76%
OM growth 5Y28.09%
PM growth 3Y15.63%
PM growth 5YN/A
GM growth 3Y-2.64%
GM growth 5Y0.68%
MELI Yearly Profit, Operating, Gross MarginsMELI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. MELI Health Analysis

2.1 Basic Checks

  • MELI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for MELI remains at a similar level compared to 1 year ago.
  • MELI has more shares outstanding than it did 5 years ago.
  • MELI has a better debt/assets ratio than last year.
MELI Yearly Shares OutstandingMELI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
MELI Yearly Total Debt VS Total AssetsMELI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 2.81 indicates that MELI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • MELI has a Altman-Z score of 2.81. This is comparable to the rest of the industry: MELI outperforms 60.00% of its industry peers.
  • MELI has a debt to FCF ratio of 0.85. This is a very positive value and a sign of high solvency as it would only need 0.85 years to pay back of all of its debts.
  • MELI's Debt to FCF ratio of 0.85 is amongst the best of the industry. MELI outperforms 83.33% of its industry peers.
  • MELI has a Debt/Equity ratio of 0.68. This is a neutral value indicating MELI is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.68, MELI is doing worse than 63.33% of the companies in the same industry.
  • Even though the debt/equity ratio score it not favorable for MELI, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 0.85
Altman-Z 2.81
ROIC/WACC1.83
WACC9.28%
MELI Yearly LT Debt VS Equity VS FCFMELI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • MELI has a Current Ratio of 1.17. This is a normal value and indicates that MELI is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.17, MELI is doing worse than 73.33% of the companies in the same industry.
  • A Quick Ratio of 1.15 indicates that MELI should not have too much problems paying its short term obligations.
  • MELI has a Quick ratio (1.15) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.15
MELI Yearly Current Assets VS Current LiabilitesMELI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. MELI Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.51% over the past year.
  • Measured over the past years, MELI shows a very strong growth in Earnings Per Share. The EPS has been growing by 60.44% on average per year.
  • Looking at the last year, MELI shows a very strong growth in Revenue. The Revenue has grown by 39.06%.
  • Measured over the past years, MELI shows a very strong growth in Revenue. The Revenue has been growing by 48.70% on average per year.
EPS 1Y (TTM)4.51%
EPS 3Y60.44%
EPS 5YN/A
EPS Q2Q%-12.53%
Revenue 1Y (TTM)39.06%
Revenue growth 3Y38.91%
Revenue growth 5Y48.7%
Sales Q2Q%44.56%

3.2 Future

  • The Earnings Per Share is expected to grow by 35.40% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, MELI will show a quite strong growth in Revenue. The Revenue will grow by 19.27% on average per year.
EPS Next Y35.36%
EPS Next 2Y36.63%
EPS Next 3Y37.07%
EPS Next 5Y35.4%
Revenue Next Year34.11%
Revenue Next 2Y29.11%
Revenue Next 3Y25.17%
Revenue Next 5Y19.27%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MELI Yearly Revenue VS EstimatesMELI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
MELI Yearly EPS VS EstimatesMELI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 100 200 300

More info and screens

Find the best growth stocksShow best growing peers

4

4. MELI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 46.72 indicates a quite expensive valuation of MELI.
  • MELI's Price/Earnings ratio is in line with the industry average.
  • MELI is valuated expensively when we compare the Price/Earnings ratio to 27.33, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 34.51, MELI can be considered very expensive at the moment.
  • MELI's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. MELI is more expensive than 66.67% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.16, MELI is valued at the same level.
Industry RankSector Rank
PE 46.72
Fwd PE 34.51
MELI Price Earnings VS Forward Price EarningsMELI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as MELI.
  • 80.00% of the companies in the same industry are more expensive than MELI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.66
EV/EBITDA 23.29
MELI Per share dataMELI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400 500

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of MELI may justify a higher PE ratio.
  • MELI's earnings are expected to grow with 37.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.32
PEG (5Y)N/A
EPS Next 2Y36.63%
EPS Next 3Y37.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MELI Dividend Analysis

5.1 Amount

  • No dividends for MELI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MELI Fundamentals: All Metrics, Ratios and Statistics

MERCADOLIBRE INC

NASDAQ:MELI (4/14/2026, 10:33:22 PM)

Premarket: 1850 +9.34 (+0.51%)

1840.66

+8.73 (+0.48%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)02-24
Earnings (Next)05-07
Inst Owners82.77%
Inst Owner Change0.01%
Ins Owners0.26%
Ins Owner Change0%
Market Cap93.32B
Revenue(TTM)28.89B
Net Income(TTM)2.00B
Analysts83.87
Price Target2598.08 (41.15%)
Short Float %2.21%
Short Ratio1.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.17%
Min EPS beat(2)-12.64%
Max EPS beat(2)-5.7%
EPS beat(4)1
Avg EPS beat(4)-4.66%
Min EPS beat(4)-15.3%
Max EPS beat(4)14.99%
EPS beat(8)4
Avg EPS beat(8)5.59%
EPS beat(12)7
Avg EPS beat(12)3.94%
EPS beat(16)10
Avg EPS beat(16)6.86%
Revenue beat(2)2
Avg Revenue beat(2)1.02%
Min Revenue beat(2)0.61%
Max Revenue beat(2)1.44%
Revenue beat(4)3
Avg Revenue beat(4)1.88%
Min Revenue beat(4)-0.1%
Max Revenue beat(4)5.59%
Revenue beat(8)6
Avg Revenue beat(8)3%
Revenue beat(12)10
Avg Revenue beat(12)2.83%
Revenue beat(16)13
Avg Revenue beat(16)3.26%
PT rev (1m)-8.98%
PT rev (3m)-9.17%
EPS NQ rev (1m)-8.71%
EPS NQ rev (3m)-19.87%
EPS NY rev (1m)-8.86%
EPS NY rev (3m)-13.56%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)5.57%
Revenue NY rev (1m)1.45%
Revenue NY rev (3m)4.47%
Valuation
Industry RankSector Rank
PE 46.72
Fwd PE 34.51
P/S 3.23
P/FCF 8.66
P/OCF 7.7
P/B 13.83
P/tB 14.24
EV/EBITDA 23.29
EPS(TTM)39.4
EY2.14%
EPS(NY)53.33
Fwd EY2.9%
FCF(TTM)212.49
FCFY11.54%
OCF(TTM)238.97
OCFY12.98%
SpS569.88
BVpS133.1
TBVpS129.23
PEG (NY)1.32
PEG (5Y)N/A
Graham Number343.497 (-81.34%)
Profitability
Industry RankSector Rank
ROA 4.68%
ROE 29.59%
ROCE 22.81%
ROIC 16.97%
ROICexc 30.8%
ROICexgc 31.6%
OM 11.08%
PM (TTM) 6.91%
GM 44.5%
FCFM 37.29%
ROA(3y)5.96%
ROA(5y)4.44%
ROE(3y)35.22%
ROE(5y)27.5%
ROIC(3y)21.88%
ROIC(5y)17.77%
ROICexc(3y)229.5%
ROICexc(5y)162.58%
ROICexgc(3y)538.3%
ROICexgc(5y)354.16%
ROCE(3y)29.4%
ROCE(5y)23.88%
ROICexgc growth 3Y-33.3%
ROICexgc growth 5YN/A
ROICexc growth 3Y-28.99%
ROICexc growth 5YN/A
OM growth 3Y3.76%
OM growth 5Y28.09%
PM growth 3Y15.63%
PM growth 5YN/A
GM growth 3Y-2.64%
GM growth 5Y0.68%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 0.85
Debt/EBITDA 1.14
Cap/Depr 164.18%
Cap/Sales 4.65%
Interest Coverage 5.24
Cash Conversion 301.47%
Profit Quality 539.46%
Current Ratio 1.17
Quick Ratio 1.15
Altman-Z 2.81
F-Score5
WACC9.28%
ROIC/WACC1.83
Cap/Depr(3y)133.57%
Cap/Depr(5y)162.49%
Cap/Sales(3y)4.05%
Cap/Sales(5y)5%
Profit Quality(3y)459.33%
Profit Quality(5y)464.07%
High Growth Momentum
Growth
EPS 1Y (TTM)4.51%
EPS 3Y60.44%
EPS 5YN/A
EPS Q2Q%-12.53%
EPS Next Y35.36%
EPS Next 2Y36.63%
EPS Next 3Y37.07%
EPS Next 5Y35.4%
Revenue 1Y (TTM)39.06%
Revenue growth 3Y38.91%
Revenue growth 5Y48.7%
Sales Q2Q%44.56%
Revenue Next Year34.11%
Revenue Next 2Y29.11%
Revenue Next 3Y25.17%
Revenue Next 5Y19.27%
EBIT growth 1Y21.66%
EBIT growth 3Y44.14%
EBIT growth 5Y90.47%
EBIT Next Year54.93%
EBIT Next 3Y39.18%
EBIT Next 5Y30.45%
FCF growth 1Y52.64%
FCF growth 3Y63.06%
FCF growth 5Y63.03%
OCF growth 1Y53.02%
OCF growth 3Y60.33%
OCF growth 5Y59.26%

MERCADOLIBRE INC / MELI Fundamental Analysis FAQ

What is the fundamental rating for MELI stock?

ChartMill assigns a fundamental rating of 6 / 10 to MELI.


What is the valuation status for MELI stock?

ChartMill assigns a valuation rating of 4 / 10 to MERCADOLIBRE INC (MELI). This can be considered as Fairly Valued.


How profitable is MERCADOLIBRE INC (MELI) stock?

MERCADOLIBRE INC (MELI) has a profitability rating of 8 / 10.


How financially healthy is MERCADOLIBRE INC?

The financial health rating of MERCADOLIBRE INC (MELI) is 6 / 10.


What is the earnings growth outlook for MERCADOLIBRE INC?

The Earnings per Share (EPS) of MERCADOLIBRE INC (MELI) is expected to grow by 35.36% in the next year.